This image is a representation. Your design will be featured in the final product.

ANTISCAR: Advanced Healing Solution for Chronic Wounds


ANTISCAR is a revolutionary filmogenic liquid bandage designed for the treatment of chronic wounds such as venous ulcers, pressure ulcers, and diabetic ulcers. Its unique formulation and advanced technology accelerate the healing process, reduce the risk of infection, and improve the quality of life for patients. The product is easy to apply, comfortable, and does not limit patient mobility. Clinical trials have shown significant improvements in healing time, infection rates, and overall patient quality of life.

Clinical trial

Randomized, double-blind, placebo-controlled trial

Population

This product is intended for adult use

Indication

 Cicatrization of venous ulcers, pressure ulcers (bedsores) and ulcers of diabetic patients

Overview


ANTISCAR is a revolutionary product for wound care, presented in the form of an innovative liquid bandage. It is specifically designed to treat chronic wounds, bedsores, and ulcers in an effective and rapid manner. Its cutting-edge technology and unique formulation accelerate the healing process and minimize complications often associated with these types of skin lesions.

 

The Protective Barrier and Hydrating Agents

ANTISCAR employs specific polymers capable of forming a protective barrier on the wound. This barrier prevents bacteria from entering the wound, thereby minimizing the risk of infection. Additionally, ANTISCAR contains hydrating agents that maintain a moist environment conducive to cellular and tissue regeneration, a crucial step for effective healing.

  

Ease of Use and Comfort

Our product is not only effective but also easy to use. It does not require any specific equipment for its application. Moreover, the product is discreet and flexible, making it comfortable for the patient and does not limit their mobility.

 

Innovative Technology: Matrix Metalloproteinases (MMPs) Inhibition

ANTISCAR utilizes an innovative technology of Matrix Metalloproteinases (MMPs) inhibition. MMPs are enzymes that degrade the components of the extracellular matrix, a structure that supports and surrounds cells in tissues. An excess of MMP activity can hinder healing. ANTISCAR’s technology regulates MMP activity, thereby promoting tissue regeneration and faster healing.

 

A Comprehensive Solution

ANTISCAR offers a comprehensive solution for the treatment of chronic wounds, bedsores, and ulcers. This product accelerates the healing process, protects against infections, is easy to apply, provides comfort to the patient, and utilizes innovative MMP inhibition technology for optimal healing.



Clinical Trial Results


Proving ANTISCAR’s Effectiveness

Clinical trial results demonstrate ANTISCAR’s effectiveness in treating chronic wounds and diabetic foot ulcers. The liquid bandage ANTISCAR accelerates the healing process, reduces the risk of infection, and improves the quality of life of patients. The healing time was reduced significantly in the treatment group compared to the control group. 

On average, wounds healed 2.1 times faster with the use of ANTISCAR. The healing rate, measured by the reduction in wound surface area, was significantly higher in patients treated with ANTISCAR. After 4 weeks of treatment, 56.3% of wounds in the treatment group had healed, compared to only 31.5% in the control group. 

The risk of infection was reduced by 50% with the use of ANTISCAR, which can be attributed to the protective film formed by the liquid bandage, preventing the entry of bacteria. Patients treated with ANTISCAR reported an improvement in their quality of life in terms of pain, mobility, and comfort compared to the control group.


See full publication (PDF)


Reduced healing time:

Patients in the treatment group experienced a significant reduction in healing time compared to the control group. On average, wounds healed 2.1 times faster with the use of ANTISCAR.

 

Improved healing rate:

The healing rate, measured by the reduction in wound surface area, was significantly higher in patients treated with ANTISCAR. After 4 weeks of treatment, 56.3% of wounds in the treatment group had healed, compared to only 31.5% in the control group.

 

Decreased risk of infection:

Patients in the treatment group had a significantly lower infection rate than those in the control group. The use of ANTISCAR reduced the risk of infection by 50%, which can be attributed to the protective film formed by the liquid dressing, preventing the entry of bacteria.

 

Improved quality of life:

Patients treated with ANTISCAR reported an improvement in their quality of life in terms of pain, mobility, and comfort compared to the control group.

 

These clinical results demonstrate the effectiveness of ANTISCAR in the treatment of chronic wounds and diabetic foot ulcers. The ANTISCAR liquid dressing helps to accelerate the healing process, reduce the risk of infection, and improve the quality of life of patients.




Product Details


  • Indication: Filmogenic liquid bandage for the cicatrization of venous ulcers, pressure ulcers (bedsores), and ulcers of diabetic patients.
  • Composition: Filmogenic glycerol, xanthan gum, honey, MMP-cyanidin, association of Camellia sinensis and Vaccinium myrtillus.
  • Presentation: 50ml.
  • Class: Current certification: MDD Class IIa | Certification in progress: MDR Class IIa.
  • Direction: Apply to wounds, 2-3 times a day.
  • Precautions: The product is intended for topical use only (damaged skin surface) and should not be swallowed. Keep out of reach and sight of children.
  • Age: 18+.
  • Storage conditions: Below 25°C.
  • Legal manufacturer: VITROBIO (France).
  • Product code: AS